Giving the Good Talk

Premium

As everyone knows — and has experienced — there are good talks and bad talks. The good ones often leave the audience with a sense of what the speaker studies, what's new in his lab, and why the field is important. Bad talks can leave the audience confused or trying to poke their eyes out with a conference pen. As disheartening as giving a bad talk can be, it is also a learning opportunity. "Everybody gives bad talks and, although there are exceptions, generally speaking, it tends to be better than you thought it was," says Boston University's James Galagan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.